DEFINITIVE PROXY STATEMENT

Company

Centessa Pharmaceuticals plc

Filed

May 6, 2025

Period of Report

June 20, 2025

Accession Number

0001999371-25-005478

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →